Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony P Adamis

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|December 31, 2004
Pegaptanib for neovascular age-related macular degenerationEvangelos S Gragoudas, Anthony P Adamis, Emmett T Cunningham, et al.
Ophthalmology|May 19, 2007
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration, Rajendra S Apte, Marlene Modi, et al.
The American Journal of Pathology|July 28, 2004
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathyVassiliki Poulaki, Antonia M Joussen, Nicholas Mitsiades, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2002
Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppressionAntonia M Joussen, Vassiliki Poulaki, Nicholas Mitsiades, et al.
Investigative Ophthalmology & Visual Science|January 31, 2003
Sustained inhibition of corneal neovascularization by genetic ablation of CCR5Balamurali K Ambati, Akshay Anand, Antonia M Joussen, et al.
American Journal of Ophthalmology|February 28, 2002
Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primateMichael J Tolentino, D Scott McLeod, Makoto Taomoto, et al.
The American Journal of Pathology|June 24, 2003
Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdownKenji Yamashiro, Akitaka Tsujikawa, Susumu Ishida, et al.
Molecular Vision|November 18, 2006
Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularizationNobuo Jo, Meihua Ju, Kazuaki Nishijima, et al.
Nature Reviews. Drug Discovery|March 7, 2006
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseEugene W M Ng, David T Shima, Perry Calias, et al.
Investigative Ophthalmology & Visual Science|December 31, 2002
Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheresKaren G Carrasquillo, Joseph A Ricker, Ioannis K Rigas, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|December 31, 2004
Pegaptanib for neovascular age-related macular degenerationEvangelos S Gragoudas, Anthony P Adamis, Emmett T Cunningham, et al.
Ophthalmology|May 19, 2007
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration, Rajendra S Apte, Marlene Modi, et al.
The American Journal of Pathology|July 28, 2004
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathyVassiliki Poulaki, Antonia M Joussen, Nicholas Mitsiades, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2002
Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppressionAntonia M Joussen, Vassiliki Poulaki, Nicholas Mitsiades, et al.
Investigative Ophthalmology & Visual Science|January 31, 2003
Sustained inhibition of corneal neovascularization by genetic ablation of CCR5Balamurali K Ambati, Akshay Anand, Antonia M Joussen, et al.
American Journal of Ophthalmology|February 28, 2002
Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primateMichael J Tolentino, D Scott McLeod, Makoto Taomoto, et al.
The American Journal of Pathology|June 24, 2003
Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdownKenji Yamashiro, Akitaka Tsujikawa, Susumu Ishida, et al.
Molecular Vision|November 18, 2006
Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularizationNobuo Jo, Meihua Ju, Kazuaki Nishijima, et al.
Nature Reviews. Drug Discovery|March 7, 2006
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseEugene W M Ng, David T Shima, Perry Calias, et al.
Investigative Ophthalmology & Visual Science|December 31, 2002
Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheresKaren G Carrasquillo, Joseph A Ricker, Ioannis K Rigas, et al.
Pageof 7